Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°©»ó¼± Á¾¾ç¿¡¼­ Fas ¹× Fas Ligand ¹ßÇöÀÇ ÀÓ»óÀû ÀÇÀÇ The Clinical Significance of Fas and Fas Ligand Expression in Thyroid Neoplasms

´ëÇÑ¿Ü°úÇÐȸÁö 2002³â 63±Ç 6È£ p.462 ~ 467
±èÅÂÇü, ¹Î¿¬±â, Á¶¼ºÁø, ¼Õ±æ¼ö, ¹èÁ¤¿ø, ±èÁ¾¼®, ±¸¹üȯ,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÅÂÇü ( Kim Tae-Hyoung ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

¹Î¿¬±â ( Min Youn-Ki ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
Á¶¼ºÁø ( Cho Seong-Jin ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¼Õ±æ¼ö ( Son Gil-Soo ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¹èÁ¤¿ø ( Bae Jung-Won ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±èÁ¾¼® ( Kim Chong-Suk ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±¸¹üȯ ( Koo Bum-Hwan ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract


PURPOSE: Recent studies indicate that Fas and Fas Ligand (Fas-L) are implicated in autoimmune endocrine diseases and tumors of the thyroid. In this study we tried to elucidate the expression stati of Fas and Fas-L in some kinds of thyroid neoplasms, and
their relationships with 4 prognostic factors in papillary thyroid cancer (i.e., size, lymph node metastasis, capsule invasion, age). METHODS: 66 cases of thyroid neoplasm including 45 cases of papillary cancer (PTC), 3 of a follicular cancer (FTC), 1
of a poorly differentiated cancer (PDC), 1 of a undifferentiated cancer (UC), 7 of follicular adenoma (FA), and 9 of nodular hyperplasia (NH) were examined, and estimated as negative, weak positive and strong positive about the Fas and Fas-L expression
by the immunohistochemical staining intensities. We then collected and compared the differrences between benign and malignant tumors. The expressions of Fas and Fas-L in papillary thyroid cancers were evaluated relating to the differences in the
prognostic factors (i.e., the size, lymph node status, capsule invasion, and age of the patients). RESULTS: Malignant thyroid tumors revealed stronger staining intensity than benign neoplasms. In papillary thyroid cancers, Fas-L staining intensities
were significantly stronger in the cases with perithyroidal lymph node metastasis, or in those of 45 years old or over than in those with no lymph node metastasis, or younger than 45 years. CONCLUSION: Both Fas and Fas-L are implicated in thyroid
tumorigenesis and revealed stronger staining intensities in malignant than benign tumors, and the Fas-L staining intensities may have some prognostic implications at least in papillary thyroid cancers.

Å°¿öµå

°©»ó¼± Á¾¾ç; Fas; Fas ligand (Fas-L); Thyroid neoplasms; Fas; Fas ligand (Fas-L);

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS